http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015203285-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5e77c181522ee1fd44df1ae5ac2196 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate | 2015-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665992937de8ac6f399e97730ce23a10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a760374eaa99f91f019c692ded9d01ef |
| publicationDate | 2016-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2015203285-B2 |
| titleOfInvention | Biologically Active Peptides |
| abstract | A peptide or peptide derivative comprising: (i) WDLYFEIVW (SEQ ID NO: 1 ); or (ii) a variant amino acid sequence comprising one, two, three or four L-amino acid substitutions in WDLYFEIVW (SEQ ID NO: 1 ); or (iii) the retro-inverso variant of the peptide or peptide derivative of either one of parts (i) and (ii), wherein said peptide or peptide derivative has procoagulant activity. A peptide or peptide derivative comprising: (i) an amino acid sequence comprising imfwydcye; or (ii) a variant amino acid sequence comprising one, two, three, four, five or six amino acid substitutions in imfwydcye, wherein said peptide or peptide derivative has procoagulant activity. |
| priorityDate | 2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.